468 related articles for article (PubMed ID: 17039515)
1. Hypocholesterolemia in chronic anemias with increased erythropoietic activity.
Shalev H; Kapelushnik J; Moser A; Knobler H; Tamary H
Am J Hematol; 2007 Mar; 82(3):199-202. PubMed ID: 17039515
[TBL] [Abstract][Full Text] [Related]
2. Serum transferrin receptor.
Skikne BS
Am J Hematol; 2008 Nov; 83(11):872-5. PubMed ID: 18821709
[TBL] [Abstract][Full Text] [Related]
3. [Erythropoietin in congenital anemias in children].
Pavlović-Kentera V; Cvetković P; Vuković I; Bunjevacki G; Milenković P; Biljanović-Paunović L; Stojimirović E
Bilt Hematol Transfuz; 1977; 5(3-4):125-32. PubMed ID: 615597
[TBL] [Abstract][Full Text] [Related]
4. [Influence of tumor necrosis factor-alpha and interferon-gamma on erythropoietin production and erythropoiesis in cancer patients with anemia].
Wang W; Zhang MH; Yu Y; Xu CG
Zhonghua Xue Ye Xue Za Zhi; 2007 Oct; 28(10):681-4. PubMed ID: 18399174
[TBL] [Abstract][Full Text] [Related]
5. Hypocholesterolemia in children and adolescents with beta-thalassemia intermedia.
Hartman C; Tamary H; Tamir A; Shabad E; Levine C; Koren A; Shamir R
J Pediatr; 2002 Oct; 141(4):543-7. PubMed ID: 12378195
[TBL] [Abstract][Full Text] [Related]
6. Serum erythropoietin and circulating transferrin receptor in thalassemia intermedia patients with heterogeneous genotypes.
Camaschella C; Gonella S; Calabrese R; Vischia F; Roetto A; Graziadei G; Mazza U; Cappellini MD
Haematologica; 1996; 81(5):397-403. PubMed ID: 8952151
[TBL] [Abstract][Full Text] [Related]
7. Erythropoietin and iron-restricted erythropoiesis.
Goodnough LT
Exp Hematol; 2007 Apr; 35(4 Suppl 1):167-72. PubMed ID: 17379103
[TBL] [Abstract][Full Text] [Related]
8. Lipid profile in beta-thalassemia intermedia patients: correlation with erythroid bone marrow activity.
Amendola G; Danise P; Todisco N; D'Urzo G; Di Palma A; Di Concilio R
Int J Lab Hematol; 2007 Jun; 29(3):172-6. PubMed ID: 17474893
[TBL] [Abstract][Full Text] [Related]
9. Clinical utility of serum soluble transferrin receptor levels and comparison with bone marrow iron stores as an index for iron-deficient erythropoiesis in a heterogeneous group of patients.
Chang J; Bird R; Clague A; Carter A
Pathology; 2007 Jun; 39(3):349-53. PubMed ID: 17558864
[TBL] [Abstract][Full Text] [Related]
10. [Status of iron metabolism and erythropoietic proliferation in children with various genotypes of thalassemia].
Mai HR; Li CG; Wang Y; Shi HS; Zhao WL; Chen YS; Chen XW
Zhongguo Dang Dai Er Ke Za Zhi; 2010 Aug; 12(8):602-4. PubMed ID: 20704788
[TBL] [Abstract][Full Text] [Related]
11. [Clinical importance of determining levels of circulating transferrin receptors in blood].
Cermák J; Brabec V
Vnitr Lek; 1999 Aug; 45(8):468-72. PubMed ID: 11045146
[TBL] [Abstract][Full Text] [Related]
12. The continuous erythropoietin receptor activator (C.E.R.A.) corrects anemia at extended administration intervals in patients with chronic kidney disease not on dialysis: results of a phase II study.
Provenzano R; Besarab A; Macdougall IC; Ellison DH; Maxwell AP; Sulowicz W; Klinger M; Rutkowski B; Correa-Rotter R; Dougherty FC;
Clin Nephrol; 2007 May; 67(5):306-17. PubMed ID: 17542340
[TBL] [Abstract][Full Text] [Related]
13. Expected value of serum soluble transferrin receptor, erythropoietin and ferritin and their correlation among healthy non-anemic Thai children.
Wiwanitkit V; Preechakas P; Bhokaisawan N; Boonchalermvichian C
J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S241-5. PubMed ID: 12188418
[TBL] [Abstract][Full Text] [Related]
14. Low serum levels of prohepcidin, but not hepcidin-25, are related to anemia in familial amyloidosis TTR V30M.
Beirão I; Almeida S; Swinkels D; Costa PM; Moreira L; Fonseca I; Freitas C; Cabrita A; Porto G
Blood Cells Mol Dis; 2008; 41(2):175-8. PubMed ID: 18544472
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometric reticulocyte maturity index: a useful laboratory parameter of erythropoietic activity in anemia.
Davis BH; Ornvold K; Bigelow NC
Cytometry; 1995 Mar; 22(1):35-9. PubMed ID: 7587731
[TBL] [Abstract][Full Text] [Related]
16. Erythropoiesis and serum sVCAM-1 levels in adults with sickle cell disease.
Duits AJ; Rojer RA; van Endt T; MacGillavry MR; ten Cate H; Brandjes DP; Schnog JB
Ann Hematol; 2003 Mar; 82(3):171-4. PubMed ID: 12634950
[TBL] [Abstract][Full Text] [Related]
17. Regulation of hepcidin: insights from biochemical analyses on human serum samples.
Kemna EH; Kartikasari AE; van Tits LJ; Pickkers P; Tjalsma H; Swinkels DW
Blood Cells Mol Dis; 2008; 40(3):339-46. PubMed ID: 18023212
[TBL] [Abstract][Full Text] [Related]
18. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
[TBL] [Abstract][Full Text] [Related]
19. [Cholesterol deficiency. A pathogenetic factor in chronic anemias? Preliminary report of a study in three states (author's transl)].
Pok SJ; Deutsch E; Nemesánszky E; Sas G; Pálos LA; Bräuer H; Rahlfs V; Schomann C
MMW Munch Med Wochenschr; 1980 Sep; 122 Suppl 3():S123-31. PubMed ID: 6779152
[TBL] [Abstract][Full Text] [Related]
20. The soluble transferrin receptor in dysplastic erythropoiesis in myelodysplastic syndrome.
Metzgeroth G; Rosée PL; Kuhn C; Schultheis B; Dorn-Beineke A; Hehlmann R; Hastka J
Eur J Haematol; 2007 Jul; 79(1):8-16. PubMed ID: 17532764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
